FDA Center for Drug Evaluation & Research Issues Warning Letter to Laboratorios Jaloma S.A. De C.V.
June 03, 2026
June 03, 2026
WASHINGTON, June 3 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Laboratorios Jaloma S.A. de C.V. from its Center for Drug Evaluation and Research:
* * *
Recipient: Mr. Jaime Labastida, Managing Director, Laboratorios Jaloma S.A. de C.V., Calle Emiliano Zapata, No. 422, Oblatos 44380 Guadalajara, Jal., Mexico
Issuing Office: Center for Drug Evaluation and Research (CDER), United State . . .
* * *
Recipient: Mr. Jaime Labastida, Managing Director, Laboratorios Jaloma S.A. de C.V., Calle Emiliano Zapata, No. 422, Oblatos 44380 Guadalajara, Jal., Mexico
Issuing Office: Center for Drug Evaluation and Research (CDER), United State . . .